Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

ClinicalTrials.gov ID: NCT04351243

Public ClinicalTrials.gov record NCT04351243. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)

Study identification

NCT ID
NCT04351243
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Kinevant Sciences GmbH
Industry
Enrollment
227 participants

Conditions and interventions

Conditions

Interventions

  • Gimsilumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 14, 2020
Primary completion
Nov 30, 2020
Completion
Mar 31, 2021
Last update posted
Dec 13, 2021

2020 – 2021

United States locations

U.S. sites
33
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
Banner University Medical Center Phoenix Arizona 85006
HonorHealth John C. Lincoln Medical Center Phoenix Arizona 85020
HonorHealth Scottsdale Osborn Medical Center Scottsdale Arizona 85251
HonorHealth Scottsdale Arizona 85258
HonorHealth Scottsdale Shea Medical Center Scottsdale Arizona 85260
Banner University Medical Center Tucson Arizona 85719
UCLA Ronald Reagan Medical Center Los Angeles California 90095
University of Florida Gainesville Florida 32610
Miami Cancer institute Miami Florida 33176
Piedmont Healthcare Atlanta Georgia 30309
Emory University School of Medicine Atlanta Georgia 30322
NorthShore University HealthSystem Evanston Illinois 60201
East Jefferson General Hospital Metairie Louisiana 70006
Brigham and Women's Hospital Boston Massachusetts 02115
Beaumont Hospital - Royal Oak Royal Oak Michigan 48073
Jamaica Hospital Medical Center Jamaica New York 11418
Mount Sinai Beth Israel New York New York 10003
Mount Sinai West New York New York 10019
Mount Sinai Morningside New York New York 10025
Icahn School of Medicine at Mount Sinai New York New York 10029
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Temple University Hospital Philadelphia Pennsylvania 19140
Vanderbilt University Medical Center Nashville Tennessee 37232
Baylor Jack & Jane Hamilton Heart and Vascular Hospital Dallas Texas 75226
Baylor University Medical Center Dallas Texas 75246
Baylor Scott & White All Saints Medical Center Fort Worth Texas 75061
Memorial Hermann Hospital Affiliated with University of Texas Health Science Center at Houston, McGovern Medical School Houston Texas 77030
Baylor Scott & White Medical Center Irving Texas 75061
Baylor Scott & White Heart Hospital Plano Texas 75093
Baylor Scott & White Medical Center Plano Texas 75093
Baylor Scott & White Medical Center Round Rock Texas 78665
Baylor Scott & White Medical Center Temple Texas 76508
Inova Fairfax Medical Campus Falls Church Virginia 22042

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04351243, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04351243 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →